Business Description
PMV Pharmaceuticals Inc
NAICS : 541714
SIC : 2833
ISIN : US69353Y1038
Share Class Description:
PMVP: Ordinary SharesDescription
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.28 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12 | |||||
| 3-Year EPS without NRI Growth Rate | 15.7 | |||||
| 3-Year FCF Growth Rate | 19.9 | |||||
| 3-Year Book Growth Rate | -18.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.78 | |||||
| 9-Day RSI | 53.62 | |||||
| 14-Day RSI | 51.9 | |||||
| 6-1 Month Momentum % | 38.21 | |||||
| 12-1 Month Momentum % | -61.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.78 | |||||
| Quick Ratio | 14.78 | |||||
| Cash Ratio | 14.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.7 | |||||
| Shareholder Yield % | -0.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -29.79 | |||||
| ROA % | -26.94 | |||||
| ROIC % | -187.52 | |||||
| ROC (Joel Greenblatt) % | -404.13 | |||||
| ROCE % | -32.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.4 | |||||
| Price-to-Tangible-Book | 0.4 | |||||
| EV-to-EBIT | 1.27 | |||||
| EV-to-EBITDA | 1.29 | |||||
| EV-to-FCF | 1.8 | |||||
| Price-to-Net-Current-Asset-Value | 0.5 | |||||
| Price-to-Net-Cash | 0.51 | |||||
| Earnings Yield (Greenblatt) % | 78.74 | |||||
| FCF Yield % | -62.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PMVP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PMV Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.45 | ||
| Beta | 1.53 | ||
| Volatility % | 116.65 | ||
| 14-Day RSI | 51.9 | ||
| 14-Day ATR ($) | 0.114537 | ||
| 20-Day SMA ($) | 1.66 | ||
| 12-1 Month Momentum % | -61.71 | ||
| 52-Week Range ($) | 1.175 - 9.72 | ||
| Shares Outstanding (Mil) | 51.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PMV Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PMV Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
PMV Pharmaceuticals Inc Frequently Asked Questions
What is PMV Pharmaceuticals Inc(PMVP)'s stock price today?
The current price of PMVP is $1.75. The 52 week high of PMVP is $9.72 and 52 week low is $1.18.
When is next earnings date of PMV Pharmaceuticals Inc(PMVP)?
The next earnings date of PMV Pharmaceuticals Inc(PMVP) is 2024-05-10 Est..
Does PMV Pharmaceuticals Inc(PMVP) pay dividends? If so, how much?
PMV Pharmaceuticals Inc(PMVP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers